APA (7th ed.) Citation

Gao Xiang, Min Gao, Huirong Qin, Xiaolan Shen, Huilian Huang, Xiaoqiang Hou, & Zhitao Feng. (2023). Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritis. BMC.

Chicago Style (17th ed.) Citation

Gao Xiang, Min Gao, Huirong Qin, Xiaolan Shen, Huilian Huang, Xiaoqiang Hou, and Zhitao Feng. Benefit-risk Assessment of Traditional Chinese Medicine Preparations of Sinomenine Using Multicriteria Decision Analysis (MCDA) for Patients with Rheumatoid Arthritis. BMC, 2023.

MLA (9th ed.) Citation

Gao Xiang, et al. Benefit-risk Assessment of Traditional Chinese Medicine Preparations of Sinomenine Using Multicriteria Decision Analysis (MCDA) for Patients with Rheumatoid Arthritis. BMC, 2023.